Cathepsin Prediction (2 of 2) (IMAGE) Georgia Institute of Technology Caption Georgia Tech/Emory biomedical engineering assistant professor Manu Platt (standing) and graduate student Keon-Young Park examine gels that display the activity levels of cathepsins -- protein-degrading enzymes known to accelerate atherosclerosis, osteoporosis and cancer. In a new study, the researchers developed a technique to predict from a blood sample the amount of cathepsins a specific person would produce. Credit Georgia Tech Photo: Gary Meek Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.